Navigation Links
CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System
Date:6/23/2009

Advanced Platinum Surface Maximizes Biocompatibility and Biostabilityin a Bare-Metal Stent

BURLINGTON, Mass., June 23 /PRNewswire/ -- CorNova Inc. today announced that it has received CE mark approval for its Valecor Platinum Coronary Stent System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO )

The Valecor Platinum is a next-generation cobalt-chromium bare-metal stent. Utilizing a novel ion-based implantation technology called Nanofusion(TM), the Valecor Platinum stent presents a pure platinum surface to both the lumen and artery wall to provide protection from less biocompatible components inherent in all medical-grade alloys. Platinum is known for its superior biocompatibility and biostability. In addition, the stent offers some of the thinnest struts available and a novel open cell design that maximizes flexibility and conformability, while causing minimal inflammation and tissue damage during deployment.

"The Valecor Platinum Coronary Stent System represents a major advancement over current offerings in the relatively undifferentiated $1 billion bare stent market," said S. Eric Ryan, M.D., chairman and chief executive officer of CorNova. "Because of its highly biocompatible platinum surface and its novel open cell design, it has shown superior anti-restentotic performance compared to leading bare metal stents in preclinical studies."

About CorNova

CorNova is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time, cost and patient risk. The company's FiberHalo(TM) stent deployment and post-dilatation angiopla
'/>"/>

SOURCE CorNova Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9 New Mayo Clinic resea...rolapse dramatically reduces patient hospital st...sented this week at the North Central Section of t...Ariz. ,, (Logo: http://www.newscom.com/cgi-b... Additional audio and video resources, including e...
(Date:11/9/2009)...erimental Procedure for Preteen Son - ,, PHIL...rents of children with cancer, the hopeful news is...ved for decades. Among the bad news -- treatments ..., Boys diagnosed with cancer who have reached pu...eir fertility: before undergoing cancer treatment,...
(Date:11/9/2009)...wswire/ -- , , WHAT: All PETCO stores natio... workshop facilitated by specially trained in-stor...ember 14 at 2 p.m. During the 30-minute, ...tritional needs of, their dogs and ca... good pet nutrition, receive an assessment...
(Date:11/9/2009)...in French . , , Montreal, November 9, 2009 ...e. In human bodies trillions of cells are coupled,... composed. Yet these don,t come in twos, they are...e these complex cell networks are the backbone of ...or ways to splice cell clusters down to their orig...
(Date:11/9/2009)...onstruction industry, respiratory disease, often l...r, is a major public health concern. Studies led ...inia Tech,s School of Construction, have shown tha...tive in reducing the dust that causes these health...e technology remains very low. , To find out why...
Breaking Medicine News(10 mins):Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3
...risis, YONKERS, N.Y., June 9 Some of the biggest...GE Money, Citigroup, and,Chase, are pushing risky ...,to the latest issue of Consumer Reports, which de... today, it could more,than triple to $150 billion ...
...f retina damage , , MONDAY, June 9 (Health... the progression of eye disease in diabetes patien... Eye Institute at the University of California, Lo...erience reductions in visual acuity (sharpness). B...
...kely Demand Similar,Treatment Next Year, WASHINGT...ociation (PCMA) released a new ad today warning po...ing doctors and hospitals -- would,likely demand t...ers twice as fast as all the others,will create a ...
...% reporting accidents as result , , MONDAY...ng from a lack of sleep may be a real problem for ..., Interviews with 263 students at the University o...ess. A majority in both groups reported greater da...
...tics can significantly aid healing of the severe t...births, according to researchers at Lucile Packard...versity School of Medicine and Santa Clara Valley ... common complication of childbirth. , As many as ...
...eflon chemicals likely,contaminate area residentia...eeded New Jersey,s ,alert level., - Private resid...DEP., - Testing demanded of all private drinking ...ironmental and labor groups are calling for the te...
Other Medicine News:Health News:Consumer Reports: Patients 'Overdose' on Debt As Lenders, Doctors, and Hospitals Push Risky Credit to Pay for Medical Care 2Health News:Consumer Reports: Patients 'Overdose' on Debt As Lenders, Doctors, and Hospitals Push Risky Credit to Pay for Medical Care 3Health News:Consumer Reports: Patients 'Overdose' on Debt As Lenders, Doctors, and Hospitals Push Risky Credit to Pay for Medical Care 4Health News:Diabetes Drug May Slow Eye Disease 2Health News:New PCMA Ad: Pharmacist 'Prompt Pay' Will Trigger 'Domino Effect' Among Other Medicare Providers 2Health News:Sleepy Driving Prevalent Among Collegians 2Health News:Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds 2Health News:New Jersey Coalition Calls for Investigation of Private Wells to Protect Families from PFOA in Drinking Water 2Health News:New Jersey Coalition Calls for Investigation of Private Wells to Protect Families from PFOA in Drinking Water 3
(Date:11/9/2009)..., MIAMI, Nov. 9 ISTA P...nced additional results from the Company,s Bepreve...5% Phase 3 clinical studies. These results were p...ting of the American College of Allergy, Asthma &a...In a poster presentation titled, "Treatment of Ocu...
(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCal...harmaceutical company focused on developing and co...the treatment of immune mediated diseases and canc...sident, Preclinical Development will provide an ov... Merriman Curhan Ford,s 6th Annual Investor Summit...
(Date:11/9/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswir...ay announced that on November 5, 2009, it received...q") stating that the Nasdaq Hearing Panel has gran... NASDAQ Global Market subject to the condition tha...er 31, 2009, the proposed merger (the "Merger") co...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3David Yap receives Amethyst Award 51065 1LocumTenens com Expands Service Lines to Include Primary Care 51062 1LocumTenens com Expands Service Lines to Include Primary Care 51062 2LocumTenens com Expands Service Lines to Include Primary Care 51062 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 1Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 2Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 4
...3 Telik, Inc.,(Nasdaq: TELK ) announced it will ... of TELINTRA(R) (ezatiostat HCl) Tablets at the 49...ology. The presentation is,scheduled for Saturday,...,and B4 at the Georgia World Congress Center in At...608) is titled: "Phase 1 Dose Escalation Study of,...
...ance to Phase III Clinical Trial, PALO ALTO, Cali...d: AVGO), a late-stage biotechnology company that,...eurodegenerative,diseases, today announced positiv...AL-08, the Company,s second generation proprietary...ose of the trial was to determine which,of two com...
Other Medicine Technology:Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 3Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 4
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...ELISA test kit is intended for the quantitative de...This exceptionally sensitive ELISA procedure offer...y), providing for accurate establishment of post-a...ventional methods. Furthermore, with the ability t...
...r use with 4, 8, or 12 channel pipettors. Angled s...rly all of the solution. Corners have pouring lips...rgin polystyrene containing no regrinds. Sterile 5...y irradiation. Dimensions: 78 mm W x 152 mm L x 35...
Sterile Individually Packed 100 mL Solution Basins
Medicine Products: